Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/30080
Title: | Cyclic AMP and CFTR modulation in human airway epithelial cells in the context of lung health and disease |
Other Titles: | Cyclic AMP and CFTR Modulation in the airways |
Authors: | Nguyen, Jenny P. |
Advisor: | Hirota, Jeremy A. |
Department: | Medical Sciences (Division of Physiology/Pharmacology) |
Keywords: | Air Pollution;Airway surface liquid;ATP binding cassette transporter C4;Chronic obstructive pulmonary disease;Cyclic adenosine monophosphate;Cystic fibrosis;Cystic fibrosis transmembrane conductance regulator;Diesel exhaust particles;Phosphodiesterase-4;Tobacco smoke extract |
Publication Date: | 2024 |
Abstract: | Cystic fibrosis (CF) is the most common genetic disease affecting Canadian newborns (1 in 3,850) and is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene. This gene encodes for CFTR, a phosphorylation-dependent ion channel localized at the apical membrane. Phosphorylation of CFTR by the cyclic adenosine monophosphate (cAMP)-dependent enzyme protein kinase A activates its activity, facilitating the transport of chloride and bicarbonate ions across the epithelial membrane. CFTR contributes to ion and airway surface liquid regulation, crucial for maintaining host defenses. The inheritance of CFTR mutations leads to a variety of respiratory complications, including impaired mucociliary clearance, excessive mucus production, persistent airway infections, and heightened inflammation, ultimately causing lung damage. While there is currently no cure for CF, the development of CFTR modulators, targeting the defective CFTR protein directly, has significantly improved the quality of life for many CF patients. Despite these advancements, many patients remain unresponsive to current treatment options. It has been well-established that combination therapies outperform monotherapies, emphasizing the need for alternative or complementary therapeutic strategies for CF management. Furthermore, CFTR dysfunction extends beyond CF and has been implicated in other respiratory diseases, such as chronic obstructive pulmonary disease, which is primarily linked to tobacco smoke exposure. This Ph.D. thesis explores a complementary therapeutic approach, targeting proteins within the CFTR-containing macromolecular signaling complex to elevate intracellular cAMP levels, thereby enhancing CFTR function. We hypothesized that synergistic use of cAMP modulators, alongside CFTR modulators, will serve as an effective therapeutic strategy for CF and other respiratory diseases. Collectively, our studies highlight the potential of cAMP and CFTR modulation as a therapeutic strategy for improving the treatment of CF and other respiratory diseases, warranting further investigation, offering insights for future studies, and contributes to the ongoing pursuit of improved combination treatments. |
URI: | http://hdl.handle.net/11375/30080 |
Appears in Collections: | Open Access Dissertations and Theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Nguyen_Jenny_P_FinalSubmission2024July_PhD.pdf | 5.02 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.